Esvy Purple Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
- Paid Up Capital ₹ 4.60 M
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth 18.35%
- Ebitda -2091.08%
- Net Worth 210.39%
- Total Assets 216.70%
About Esvy Purple
Esvy Purple Private Limited (EPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 April 2021 (Three years and ten months 6 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 4.60 M, as per Ministry of Corporate Affairs (MCA) records.
Neeraja Peddi and Prabhu Gajawada serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100TG2021PTC150758
- Company No.
150758
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 2021
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Esvy Purple?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prabhu Gajawada  | Director | 20-Apr-2021 | Current |
| Neeraja Peddi | Director | 20-Apr-2021 | Current |
Financial Performance of Esvy Purple.
Esvy Purple Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 18.35% increase in profit. The company's net worth Soared by an impressive increase of 210.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Esvy Purple?
Unlock access to Esvy Purple's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Adwagons Advertising Private LimitedPrabhu Gajawada is a mutual person
Esvy Life Sciences Private LimitedNeeraja Peddi and Prabhu Gajawada are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Esvy Purple?
Esvy Purple has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Esvy Purple, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Esvy Purple's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.